"Vipragen offers an extensive array of Genotoxicity studies, encompassing both in vitro and in vivo assessments to identify potential mutagenic, clastogenic and aneugenic compounds capable of causing DNA damage, chromosomal structural changes and disruptions in the mitotic apparatus, and variations in chromosome number, respectively.
Vipragen's Genotoxicity services include validated tests and their respective methodologies and deliverables such as:"